$GNTOF Balance Sheet | Understand Stock

$GNTOF

$0.02 +$0.00 (0.5%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q4 FY2011 As of Dec 31, 2011
ASSETS
Current
Cash
Prepaids and advances
Accounts receivable
Due from related parties
Advances receivable
Total current assets

Capital assets
Mineral properties (note 6)
Assets from discontinued operations
Long term deposit
Mineral properties
Total assets

LIABILITIES
Current
Accounts payable
Accrued liabilities
Note payable (note 9)
Loan payable- current portion (note 10)
Canadian dollar common share purchase warrants (note 9e)
Common share purchase warrants liability
Due to related parties
Total current liabilities
Loan payable- long term portion (note 10)

Liabilities from discontinued operations
Common share purchase warrants liability
Loan
Total liabilities
SHAREHOLDERS' DEFICIENCY
Preferred stock, value
Authorized 500,000,000 Common Shares, $0.0008 per share par value Issued and outstanding 38,906,742 Common Shares (December 31, 2024 - 38,906,742)
Additional paid-in capital
Deficit accumulated during the exploration stage
Total shareholders' deficiency

Total liabilities and shareholders' deficiency

Comments